✦ New CED Clinical Relevance #72 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. PediatricsMental HealthSafetyTHC Why This Matters Clinicians treating adolescents need to recognize that modern cannabis products...
Children’s National Hospital sees more cannabis addiction among teens and tweens – WTOP News
✦ New CED Clinical Relevance #72 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. PediatricsMental HealthTHCSafetyResearch Why This Matters Clinicians treating adolescents need to recognize that modern cannabis products...
Endocannabinoid System Research: Cannabis Use & Child ASD
Clinical Takeaway Children exposed to cannabis during the peripregnancy period showed associations with behavioral and developmental differences in early childhood, and these associations varied depending on whether ASD symptoms were present. The...
Cannabinoid Clinical Trials: Teen Cannabis Intervention Study
Clinical Takeaway Research suggests that standard cannabis prevention messaging often fails teens because it does not account for the wide range of beliefs young people hold about cannabis use. This study tested...
Cannabidiol for Lennox-Gastaut: Cannabinoid Clinical Trials
Clinical Takeaway Plant-derived cannabidiol (CBD) oral solution produced meaningful reductions in drop seizures in patients with Lennox-Gastaut syndrome at thresholds below the traditional 50% benchmark used in clinical trials. Caregiver-reported outcomes aligned...
Cannabinoid Clinical Trials: CBD Gel Safety in Fragile X
Clinical Takeaway Transdermal cannabidiol gel (ZYN002) has been studied in children and adolescents with Fragile X syndrome through an open-label extension trial focused on long-term safety and tolerability. Early interim data suggest...
Endocannabinoid System Research: Cannabis Use in Pregnancy
Clinical Takeaway Children born to mothers who used cannabis during pregnancy showed a modestly elevated risk of autism spectrum disorder and a smaller increase in risk of ADHD, based on a pooled...
Endocannabinoid System Research: Cannabis & Autism Review
Clinical Takeaway Cannabinoid-based treatments, including CBD-rich preparations, have shown preliminary benefits for certain autism-related symptoms such as irritability, hyperactivity, and sleep difficulties in clinical trial data. The evidence base remains limited in...
Endocannabinoid System Research: Cannabinoids for Children
Clinical Takeaway Cannabinoids have been studied across a wide range of medical conditions in children under 18, with evidence drawn from interventional trials, observational studies, surveys, and qualitative research. The review is...
Daily Digest: Last 48 Hours: Adolescent Risk, Aging Brains, and the Long Road to Pharmaceutical-Grade Cannabis — March 04, 2026
A synthesis of 53 recently added cannabis articles — key themes, clinical context, and Dr. Caplan’s take.